Diabetes

Long-term ICS use in COPD is linked to increased risks of Type 2 diabetes, pneumonia, fractures, and more.

Oral semaglutide reduces cardiovascular events in type 2 diabetes, independent of SGLT2i therapy, with no safety concerns.

A study has demonstrated the feasibility of a mobile health-supported home-delivered physical activity programme for individuals recently diagnosed with Type 2 diabetes.

A recent study explored impact of hypertension and type 2 diabetes on kidney structure, revealing similar damage in both conditions.

Semaglutide use in diabetic patients linked to increased risk of NAION after two years of treatment.

New research shows that animal and total protein intake could reduce the risk of gestational diabetes during pregnancy.

A new predictive model helps personalise glucose-lowering therapy for type 2 diabetes, improving glycaemic control and reducing complications.

Poor sleep quality in geriatric type 2 diabetes patients is linked to worse glycaemic control and complications.